SIC
IART icon

SJS Investment Consulting’s Integra LifeSciences IART Stock Holding History

SJS Investment Consulting’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$55 – 1652
2024
Q3 		$55 Sell
3
-5
-63% -$116 ﹤0.01% 1610
2024
Q2 		$234 Sell
8
-7
-47% -$208 ﹤0.01% 1476
2024
Q1 		$532 Sell
15
-1
-6% -$40 ﹤0.01% 1264
2023
Q4 		$697 Buy
16
+5
+45% +$197 ﹤0.01% 1109
2023
Q3 		$421 Sell
11
-3
-21% -$126 ﹤0.01% 1271
2023
Q2 		$576 Sell
14
-6
-30% -$289 ﹤0.01% 1113
2023
Q1 		$1.15K Buy
20
+3
+18% +$169 ﹤0.01% 834
2022
Q4 		$953 Buy
17
+9
+113% +$458 ﹤0.01% 954
2022
Q3 		$0 Buy
+8
New +$410 ﹤0.01% 1262
2022
Q1 		$0 Buy
+2
New +$132 ﹤0.01% 997

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SJS Investment Consulting's IART Position: Q4 2024 in Review

SJS Investment Consulting sold out of Integra LifeSciences (IART) in Q4 2024, closing a stake of 3 shares — an estimated $55 sold.

SJS Investment Consulting first reported a position in IART in Q1 2022 and held it in 10 quarters. The position peaked at $1.15K in Q1 2023. 223 funds tracked by Wall St. Rank hold IART as of Q4 2024.

  • SJS Investment Consulting reported no remaining Integra LifeSciences position as of Q4 2024 after selling out during the quarter.
  • SJS Investment Consulting sold 3 Integra LifeSciences shares in Q4 2024, an estimated $55.
  • SJS Investment Consulting first reported a position in Integra LifeSciences in Q1 2022 and held it in 10 quarters.
  • SJS Investment Consulting's Integra LifeSciences position peaked at $1.15K in Q1 2023.
  • 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2024.

Based on SJS Investment Consulting's 13F filing for Q4 2024, filed 21 Jan 2025.